References
Volz M, Kellner HM (1980) Kinetics and metabolism of pyrasolones (propyphenazone, aminopyrine, dipyrone). Br J Clin Pharmacol 10 [Suppl 2]: 299–308
Vlahov V, Badian M, Verho M, Bacracheva N (1990) Pharmacokinetics of metamizol metabolites in healthy subjects after a single oral dose of metamizol sodium. Eur J Clin Pharmacol 38: 61–65
Levy M, Flusser D, Zylber-Katz E, Granit L (1984) Plasma kinetics of dipyrone metabolites in rapid and slow acetylators. Eur J Clin Pharmacol 2: 453–458
Damm D (1989) Simultaneous determination of the main metabolites of dipyrone by HPLC. Arzneimittelforschung/Drug Res 39: 1415–1417
Zylber-Katz E, Granit L, Levy M (1992) Formation and excretion of dipyrone metabolites in man. Eur J Clin Pharmacol 42: 187–191
Boobis AR, Brodie MJ, Kahn CC, Toverud EL, Blair IA, Murray SS, Davies DS (1981) Comparison of the in vivo and in vitro rates of formation of the three main oxidative metabolites of antipyrine in man. Br J Clin Pharmacol 12: 771–777
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bacracheva, N., Vlahov, V. The acetylation phenotype: does it contribute to the non-linearity of the metabolite pharmacokinetics of metamizol?. Eur J Clin Pharmacol 48, 79–80 (1995). https://doi.org/10.1007/BF00202178
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00202178